Pharmafile Logo

What oncologists really want from booth strategy

August 19, 2025 | Congress, Inizio, oncology 

- PMLiVE

Simon Davenport, Global Head of Environments, Emota, an Inizio Engage company 

At this year’s ASCO® congress, the spotlight wasn’t just on science – it was on how the industry engages. Supporting over 30 clients and delivering 185 projects, Inizio witnessed the shift toward smarter, more sustainable congress environments.

Key takeaways included:

  • Oncologists want interactive learning: Engagement is moving beyond slides, with responsive booths, interactive LED walls, and digital-first experiences extending conversations well past the industry’s six-minute average.

  • Smart spaces are here to stay: With heat mapping, AI-powered personalization, and real-time content optimization, booths are evolving into dynamic, intelligent environments that adapt to audience needs.

  • Sustainability as strategy: Inizio’s circularity-first booth design delivered a 70% CO₂e reduction, 70.7% recyclability, and major cost savings – results that earned industry-leading awards and set a benchmark for measurable impact.

In a crowded oncology market, strategy-led storytelling, analytics-driven design, and sustainability-centered innovation are becoming essential to cut through the noise. The future of congress engagement will be intentional, data-informed, and deeply aligned with healthcare professionals’ learning preferences.

Read Simon’s full article here, or explore more in Inizio’s on-demand webinar Beyond the booth: Big ideas, smart spaces & strategic insights from ASCO® 2025.

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

5 takeaways from Reuters’ Pharma USA 2026 – and what they mean for you

Pharma USA is North America’s largest cross-functional pharma event and Inizio was there to offer insights on patient engagement, accelerated product launches, and Intelligent Commercialization™. Now we’re back in the...

Precision Medical Affairs in Action: Using AI and Analytics to Elevate Strategy, Engagement, and Impact

Discover how AI, analytics and real-world data are reshaping Medical Affairs.

How did multifaceted support from across Inizio help a biotech firm prepare for launch?

Discover how teams from across Inizio provided a range of integrated services to give a client's product the best chance of launch success.

Our key takeaways from ISMPP EU 2026 – Evolving with Purpose: Excellence in an Era of Efficiency

Explore Inizio Medical's key takeaway from ISMPP EU 2026, including AI governance, transparency, patient partnership and evolving impact measurement.

Intelligent field team engagement: Turning shared knowledge into deeper insights and better decisions.

At Age of AI 2026, Inizio Medical’s Phil Wakefield and Inizio Ignite’s Tim Luxford will explore how cross-functional collaboration and AI can unlock faster, more actionable insights across medical and...

AI in practice: 4 real-world use cases in health and life sciences

Artificial Intelligence (AI) is often discussed in broad terms, with promises of transformation at scale. In practice, however, its value is realized in far more specific ways – when it...

How will AI change field training?

Learn how a next-generation approach to field training – powered by GenAI and avatar simulations and enabled through Intelligent Commercialization™ – can transform field force effectiveness by delivering scalable, always-on,...

Inizio Ignite Sparks a New Era of Connected Advisory Solutions

Inizio, a leading global commercialization partner for pharma and life sciences, today unveiled Inizio Ignite, a reimagined, fully integrated advisory partner designed to accelerate pharma performance through strategy, insights, and innovation.

MM+M Podcast explores AI-powered audience intelligence with Inizio Evoke

The MM+M Podcast features a conversation with Jamie Avallone, Chief Data Officer at Inizio Evoke, and Iris Lin, Product Science Lead at Inizio Evoke, who share their perspectives on what...

Inizio Engage CEO Jim Sage featured in pharmaphorum’s “12 Questions” series

Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum “12 Questions” interview.